PAT Guidance Will Draw From Existing Electronic Records Guidances
This article was originally published in The Tan Sheet
Executive Summary
FDA plans to draw from existing guidances to clarify 21 CFR Part 11 electronic record/electronic signature requirements in its planned PAT guidance